
Benjamin Garmezy, MD, discusses personalizing mHSPC treatment intensification based on disease burden, molecular biomarkers, and patient-specific factors.
“Clinically speaking, it really can harm patients to have gaps in both the data and their care,” says Shirley Lee, CRNP-FNP, MPH.
In this video, Shirley Lee, CRNP-FNP, MPH, discusses gaps in care and how not closing them can be harmful to patients. Lee is director of a patient navigation program and a nurse practitioner for the Greater Los Angeles Division of Genesis Healthcare Partners and Vice President of Clinical Strategy for Preveta.






